Cargando…

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition

Detalles Bibliográficos
Autores principales: Fenerty, Kathleen E., Padget, Michelle, Wolfson, Benjamin, Gameiro, Sofia R., Su, Zhen, Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Hodge, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718203/
https://www.ncbi.nlm.nih.gov/pubmed/31477176
http://dx.doi.org/10.1186/s40425-019-0715-9
_version_ 1783447699512623104
author Fenerty, Kathleen E.
Padget, Michelle
Wolfson, Benjamin
Gameiro, Sofia R.
Su, Zhen
Lee, John H.
Rabizadeh, Shahrooz
Soon-Shiong, Patrick
Hodge, James W.
author_facet Fenerty, Kathleen E.
Padget, Michelle
Wolfson, Benjamin
Gameiro, Sofia R.
Su, Zhen
Lee, John H.
Rabizadeh, Shahrooz
Soon-Shiong, Patrick
Hodge, James W.
author_sort Fenerty, Kathleen E.
collection PubMed
description
format Online
Article
Text
id pubmed-6718203
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67182032019-09-06 Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition Fenerty, Kathleen E. Padget, Michelle Wolfson, Benjamin Gameiro, Sofia R. Su, Zhen Lee, John H. Rabizadeh, Shahrooz Soon-Shiong, Patrick Hodge, James W. J Immunother Cancer Correction BioMed Central 2019-09-02 /pmc/articles/PMC6718203/ /pubmed/31477176 http://dx.doi.org/10.1186/s40425-019-0715-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Fenerty, Kathleen E.
Padget, Michelle
Wolfson, Benjamin
Gameiro, Sofia R.
Su, Zhen
Lee, John H.
Rabizadeh, Shahrooz
Soon-Shiong, Patrick
Hodge, James W.
Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title_full Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title_fullStr Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title_full_unstemmed Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title_short Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
title_sort correction to: immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (adcc)–mediating agents with poly (adp-ribose) polymerase (parp) inhibition
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718203/
https://www.ncbi.nlm.nih.gov/pubmed/31477176
http://dx.doi.org/10.1186/s40425-019-0715-9
work_keys_str_mv AT fenertykathleene correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT padgetmichelle correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT wolfsonbenjamin correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT gameirosofiar correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT suzhen correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT leejohnh correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT rabizadehshahrooz correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT soonshiongpatrick correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition
AT hodgejamesw correctiontoimmunotherapyutilizingthecombinationofnaturalkillerandantibodydependentcellularcytotoxicityadccmediatingagentswithpolyadpribosepolymeraseparpinhibition